Osteoarthritis (OA)

Osteoarthritis (OA) is a joint disease involving cartilage degradation. It’s not clear what exactly causes OA, but some risk factors include joint injury, overweight or obesity, aging, misaligned joints, and family history. Lots of supplements have been studied in people with OA, as have lifestyle interventions including weight loss and exercise.

Quick Answer

What it is

Osteoarthritis (OA) is a joint disease involving cartilage degradation. It’s not clear what exactly causes OA, but some risk factors include joint injury, overweight or obesity, aging, misaligned joints, and family history.

Key findings

  • Grade A: Knee Osteoarthritis Pain (vs NSAID) (Systemic Enzymes (Bromelain/Trypsin/Rutin))
  • Grade A: Joint Function in Osteoarthritis (Systemic Enzymes (Bromelain/Trypsin/Rutin))
  • Grade A: Safety vs NSAIDs (Systemic Enzymes (Bromelain/Trypsin/Rutin))

Safety

  • It’s not clear what exactly causes OA, but some risk factors include joint injury, overweight or obesity, aging, misaligned joints, and family history.
  • RCT (n=150): Adverse events similar to placebo (7.2% vs 9.1%) and lower than diclofenac (15.6%).
  • RCT vs diacerhein: Significantly lower adverse event rate.
ℹ️ Quick Facts

Quick Facts: Osteoarthritis (OA)

  • Supplements Studied:33
  • Research Trials:67
  • Total Participants:44,117
  • Grade A Supplements:1
  • Top Supplement:Systemic Enzymes (Bromelain/Trypsin/Rutin) (A)
67 trials
44,117 ppts
33 supps · 116 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Strong Evidence

Primary Stack (Tier 1)

1500mg glucosamine + 1200mg chondroitin daily

Provides building blocks for cartilage repair, inhibits degradative enzymes, and stimulates proteoglycan synthesis

50 studies | 10,000 participants
500-1000mg daily (enhanced absorption formula)

Potent anti-inflammatory that inhibits NF-κB, COX-2, and MMPs while protecting cartilage from degradation

25 studies | 2,000 participants

Supporting Stack (Tier 2)

100-250mg AKBA standardized extract daily

Boswellic acids inhibit 5-lipoxygenase and leukotrienes, reducing inflammation and protecting cartilage

15 studies | 800 participants

Inhibits IL-1 induced collagenase and stromelysin, promoting cartilage repair and reducing inflammation

10 studies | 2,000 participants
40mg undenatured type II collagen daily

Undenatured collagen induces oral tolerance, reducing autoimmune cartilage destruction

8 studies | 500 participants
1500-6000mg daily

Provides sulfur for connective tissue synthesis and has anti-inflammatory and antioxidant properties

12 studies | 600 participants
2-4g EPA/DHA daily

EPA/DHA reduce pro-inflammatory eicosanoids and cytokines, decreasing joint inflammation

20 studies | 1,500 participants

How It Works

Osteoarthritis is a degenerative joint disease where cartilage—the smooth tissue that cushions your joints—breaks down over time. This causes pain, stiffness, and reduced mobility. Unlike inflammatory arthritis, OA is primarily a 'wear and tear' condition, though inflammation does play a role. This protocol targets both cartilage protection and inflammation reduction.

Glucosamine + Chondroitin are the most studied supplements for osteoarthritis. Both are natural components of cartilage. Glucosamine is used to build proteoglycans (the spongy material in cartilage), while chondroitin helps retain water in cartilage and inhibits enzymes that break it down. The large GAIT trial found this combination particularly effective for moderate-to-severe knee OA pain. Results take 8-12 weeks to appear, but effects can be substantial with continued use.
Curcumin (from turmeric) is a potent anti-inflammatory that works differently from NSAIDs. It blocks NF-κB, a key inflammatory pathway, and inhibits enzymes that degrade cartilage. Studies show curcumin can reduce OA pain comparably to ibuprofen, but without the gastrointestinal side effects. Use enhanced absorption formulas (with piperine, phospholipids, or micronization) as regular curcumin is poorly absorbed.
Boswellia Serrata (Indian frankincense) contains boswellic acids that specifically inhibit 5-LOX, an enzyme that produces inflammatory leukotrienes. Unlike NSAIDs, it doesn't damage the stomach lining. Studies show significant improvements in pain, stiffness, and physical function within 1-2 weeks.
Avocado/Soybean Unsaponifiables (ASU) are oils extracted from avocados and soybeans that protect cartilage and reduce inflammation. They inhibit the IL-1 pathway that drives cartilage destruction. European studies show ASU can slow structural progression of hip OA.
Type II Collagen (UC-II) works through a unique mechanism called 'oral tolerance.' Taking small amounts of undenatured collagen teaches your immune system not to attack cartilage. Studies show it can outperform glucosamine/chondroitin for pain relief.
MSM provides sulfur, which is essential for making collagen and other connective tissue. It also has anti-inflammatory and antioxidant effects. Often combined with glucosamine for enhanced benefit.
Omega-3 Fatty Acids reduce the production of inflammatory prostaglandins and leukotrienes. While they won't rebuild cartilage, they help control inflammation and may reduce the need for NSAIDs.

Expected timeline: Boswellia and curcumin may show benefits within 1-4 weeks. Glucosamine/chondroitin require 8-12 weeks. Type II collagen: 4-8 weeks. ASU: 2-3 months for full effect.

Generated from peer-reviewed researchSchema v2.0

Supplements for Osteoarthritis (OA)

Sorted by strength of evidence

ASystemic Enzymes (Bromelain/Trypsin/Rutin)
1
Knee Osteoarthritis Pain (vs NSAID)ImprovesJoint Function in OsteoarthritisImprovesSafety vs NSAIDsImproves
BCurcumin
2
C-Reactive Protein (CRP)ImprovesBilirubinPainImproves
BAvocado/Soybean Unsaponifiables
1
Osteoarthritis SymptomsImproves
BDevil's Claw (Harpagophytum procumbens)
1
Osteoarthritis Pain (vs NSAID)ImprovesJoint Function (WOMAC)ImprovesSafety vs NSAIDs/DMOADsImproves
BResveratrol
1
Blood Urea Nitrogen (BUN)ImprovesSerum AlbuminImprovesUric AcidImproves
BChondroitin
1
PainImprovesOsteoarthritis SymptomsImproves
BPycnogenol
1
Osteoarthritis SymptomsImprovesPainWorsens
BGlucosamine
1
Osteoarthritis SymptomsImprovesPainImprovesTemporomandibular Disorder (TMD) SymptomsImproves
CRose Hip
2
ChemotaxisImprovesC-Reactive Protein (CRP)Osteoarthritis SymptomsImproves
CBoswellia
1
Asthma SymptomsImprovesC-Reactive Protein (CRP)Osteoarthritis SymptomsImproves
CMicrolactin
1
Osteoarthritis SymptomsImprovesPainImproves
CAshwagandha
1
Osteoarthritis SymptomsImprovesPainImproves
CArnica
1
Pain/FunctionImproves
CArtemisia annua
1
Long-term Safety/EfficacyWorsens
CL-Carnitine
1
C-Reactive Protein (CRP)ImprovesOsteoarthritis SymptomsImprovesPainImproves
CManganese
1
Joint PainImprovesCartilage HealthImproves
CBoron
1
C-Reactive Protein (CRP)ImprovesErythrocyte Sedimentation RateWorsensFibrinogenImproves
CGinger (Zingiber officinale)
1
InflammationImprovesOsteoarthritis SymptomsWorsensPainWorsens
CKrill Oil
1
C-Reactive Protein (CRP)ImprovesArthritis (In General)ImprovesFunctionality in Elderly or InjuredImproves
CMSM
1
Osteoarthritis SymptomsImprovesPainImproves

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
A
Knee Osteoarthritis Pain (vs NSAID)
Individual patient-level meta-analysis (6 RCTs, n=697, 2016): OEC (bromelain/trypsin/rutoside) showed equivalent efficacy to diclofenac for Lequesne Algofunctional Index improvement. RCT (n=150, 12 weeks): Wobenzym comparable to diclofenac; both superior to placebo (P<0.05).
moderateImproves
A
Joint Function in Osteoarthritis
Pooled analysis (6 RCTs): Significant improvement in joint function comparable to diclofenac. Narrative review (9 RCTs): OEC consistently improved Lequesne scores. Reduces reliance on rescue analgesic medication.
moderateImproves
A
Safety vs NSAIDs
RCT (n=150): Adverse events similar to placebo (7.2% vs 9.1%) and lower than diclofenac (15.6%). Meta-analysis: Better GI safety profile than NSAIDs. Appropriate for long-term use in patients who cannot tolerate NSAIDs.
moderateImproves
A
Osteoarthritis Pain
Phase 3 TRIUMPH-4: WOMAC pain score reduced by 4.5 points (75.8%) at 68 weeks. 12% of patients on 12mg achieved complete pain freedom vs 4.2% placebo. Likely secondary to weight loss reducing joint stress.
largeImproves
B
Pain
Small Improvement
18 studies
smallImproves
B
Osteoarthritis Symptoms
Small Improvement
9 studies
smallImproves
B
Blood Urea Nitrogen (BUN)
Small Decrease
17 studies
smallImproves
?
Serum Albumin
10 studies
Improves
?
Uric Acid
4 studies
Improves
?
Kidney Function
3 studies
Improves
?
Osteoarthritis Symptoms
1 study
Improves
?
Pain
1 study
Improves
B
Osteoarthritis Symptoms
Small Improvement
10 studies
smallImproves
B
Pain
Small Improvement
5 studies
smallImproves
?
Temporomandibular Disorder (TMD) Symptoms
4 studies
Improves
B
Osteoarthritis Symptoms
Small Improvement
5 studies
smallImproves
B
C-Reactive Protein (CRP)
Small Decrease
3 studies
smallImproves
D
Bilirubin
No effect
1 study
none
?
Pain
6 studies
Improves
?
Interleukin 1-beta
3 studies
Improves
?
Functionality in Elderly or Injured
2 studies
Improves
?
Hemoglobin
2 studies
Improves
?
Interleukin 6
2 studies
Improves
?
Osteoarthritis Symptoms
2 studies
Improves
?
Cell Adhesion Factors
1 study
Improves
?
Collagen Degradation
1 study
Worsens
?
Erythrocyte Sedimentation Rate
1 study
Improves
?
Inflammation
1 study
Improves
?
Kidney Function
1 study
Improves
?
Oxidative Stress Biomarkers
1 study
Improves
?
Prostaglandin E2
1 study
Improves
?
TNF-Alpha
1 study
Improves
?
White Blood Cell Count
1 study
Improves
B
Osteoarthritis Symptoms
Moderate Improvement
2 studies
moderateImproves
?
Pain
1 study
Worsens
B
Osteoarthritis Pain (vs NSAID)
RCT (n=122, 4 months): Harpagophytum 2610mg/day equivalent to diacerhein 100mg/day for hip/knee OA. No significant difference in pain, disability, or Lequesne score. Significantly reduced need for analgesic and NSAID co-medication.
moderateImproves
B
Joint Function (WOMAC)
Observational study (n=75, 12 weeks, 50mg harpagoside/day): WOMAC subscale improvements - pain 23.8%, stiffness 22.2%, physical function 23.1%. Consistent improvement across all domains.
moderateImproves
B
Safety vs NSAIDs/DMOADs
RCT vs diacerhein: Significantly lower adverse event rate. Diarrhea in 8.1% (Devil's Claw) vs 26.7% (diacerhein). Cochrane: Low to moderate quality evidence shows few side effects. Better GI safety profile than NSAIDs.
moderateImproves
B
Rescue Medication Reduction
Cochrane review: Devil's Claw may reduce use of rescue medication compared to placebo. RCT vs diacerhein: Significantly reduced need for analgesic (acetaminophen-caffeine) and NSAID (diclofenac) co-medication.
moderateImproves
?
Osteoarthritis Symptoms
1 study
Worsens
C
Joint Pain
Small Decrease
3 studies
smallImproves
C
Cartilage Health
Small Increase
2 studies
smallImproves
C
Osteoarthritis Symptoms
Small Improvement
3 studies
smallImproves
?
Pain
1 study
Improves
C
C-Reactive Protein (CRP)
Moderate Decrease
2 studies
moderateImproves
C
Arthritis (In General)
Moderate Improvement
1 study
moderateImproves
?
Functionality in Elderly or Injured
1 study
Improves
?
Pain
1 study
Improves
?
Quality of Life
1 study
Improves
C
Osteoarthritis Symptoms
Small Improvement
2 studies
smallImproves
?
Pain
2 studies
Improves
C
Chemotaxis
Small Decrease
1 study
smallImproves
D
C-Reactive Protein (CRP)
No effect
1 study
none
?
Osteoarthritis Symptoms
3 studies
Improves
?
Pain
2 studies
Improves
C
Asthma Symptoms
Small Improvement
1 study
smallImproves
D
C-Reactive Protein (CRP)
No effect
1 study
none
?
Osteoarthritis Symptoms
Improvement
3 studies
Improves
?
Pain
Improvement
3 studies
Improves
?
Interleukin 6
1 study
Worsens
?
Subjective Well-Being
1 study
Improves
C
Osteoarthritis Symptoms
Small Improvement
1 study
smallImproves
?
Pain
1 study
Improves
C
Osteoarthritis Symptoms
Moderate Improvement
1 study
moderateImproves
?
Pain
1 study
Improves
C
Pain/Function
Topical gel (50% tincture) effective for OA symptoms
1 study
moderateImproves
C
Long-term Safety/Efficacy
6-month open-label extension showed maintained benefits with continued safety
1 study
moderateWorsens
C
C-Reactive Protein (CRP)
Moderate Decrease
1 study
moderateImproves
?
Osteoarthritis Symptoms
3 studies
Improves
?
Pain
2 studies
Improves
?
High-density lipoprotein (HDL)
1 study
Improves
?
Interleukin 1-beta
1 study
Improves
?
Low-density lipoprotein (LDL)
1 study
Improves
?
Matrix Metalloproteinase 1
1 study
Improves
?
Matrix Metalloproteinase 13
1 study
Improves
?
Matrix Metalloproteinase 3
1 study
Improves
?
Oxidative Stress Biomarkers
1 study
Improves
?
TNF-Alpha
1 study
Improves
?
Total Antioxidant Capacity (TAC)
1 study
Improves
?
Total cholesterol
1 study
Improves
C
C-Reactive Protein (CRP)
Moderate Decrease
1 study
moderateImproves
?
Erythrocyte Sedimentation Rate
1 study
Worsens
?
Fibrinogen
1 study
Improves
?
High-density lipoprotein (HDL)
1 study
Improves
?
Low-density lipoprotein (LDL)
1 study
Worsens
?
Total cholesterol
1 study
Worsens
C
Body Fat
Small Decrease
1 study
smallImproves
?
Muscle Mass
1 study
Improves
?
Osteoarthritis Symptoms
1 study
Improves
?
Power Output
1 study
Improves
?
Subjective Well-Being
1 study
Improves
C
Inflammation
Small Decrease
1 study
smallImproves
?
Osteoarthritis Symptoms
2 studies
Worsens
?
Pain
1 study
Worsens
D
Bilirubin
No effect
5 studies
none
?
Depression Symptoms
11 studies
Improves
?
Osteoarthritis Symptoms
7 studies
Improves
?
Functionality in Elderly or Injured
6 studies
Improves
?
Itching
5 studies
Improves
?
Pain
2 studies
Improves
D
Body Mass Index (BMI)
No effect
2 studies
none
?
Osteoarthritis Symptoms
4 studies
Improves
?
C-Reactive Protein (CRP)
3 studies
Improves
?
Pain
3 studies
Improves
D
Osteoarthritis Symptoms
No effect
2 studies
none
D
Joint Pain
Preliminary pain reduction observed
1 study
smallImproves
D
Collagen Content
No effect
1 study
none
?
Osteoarthritis Symptoms
1 study
Improves
?
Pain
1 study
Improves
D
Blood Pressure
No effect
1 study
none
?
Functionality in Elderly or Injured
1 study
Improves
?
Pain
1 study
Improves
?
Osteoarthritis Symptoms
11 studies
Improves
?
Osteoarthritis Symptoms
1 study
Improves
?
Osteoarthritis Symptoms
Improvement
1 study
Improves
?
Osteoarthritis Symptoms
1 study
Improves

Related Conditions

Metabolic Health

14 shared supplements · 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

Type 2 Diabetes

12 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

High Cholesterol

11 shared supplements · 553 outcomes

High amounts of low-density lipoproteins cause fatty plaques to build up in the arteries, which restricts blood flow and can cause health problems like a heart attack. Lifestyle factors (e.g., poor diet, smoking) and genetics play a huge role in blood cholesterol levels.

Obesity

10 shared supplements · 525 outcomes

Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.

10 shared supplements · outcomes

Overweight

9 shared supplements · 379 outcomes

Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).

General Athletic Performance

9 shared supplements · 656 outcomes

General athletic performance refers to an individual's ability to perform in various sports and physical activities, including strength, speed, endurance, and agility.

Bone Health

9 shared supplements · 82 outcomes

Bone health refers to the strength of bones and the quality of bone structure. Bone health is usually measured as bone mineral density. Bone health is affected by nutrient intake, hormonal regulation, exercise, and age, among other factors.